SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients
Benjamin Charvet, Joanna Brunel, Justine Pierquin, Mathieu Iampietro, Didier Décimo, Nelly Queruel, Alexandre Lucas, María del Mar Encabo-Berzosa, Izaskun Arenaz, Tania Perez Marmolejo, Arturo Ivan Gonzalez Gonzalez, Armando Castorena-Maldonado, Cyrille Mathieu, Patrick Küry, José Flores‐Rivera, Fernanda Torres-Ruiz, Santiago Ávila‐Ríos, Gonzalo Salgado-Montes de, Jon Schoorlemmer, Hervé Perron, Branka Horvat
Abstract
exposure to SARS-CoV-2 activates the expression of the human endogenous retrovirus (HERV) HERV-W proinflammatory envelope protein (ENV) in peripheral blood mononuclear cells from a subset of healthy donors, in ACE2 receptor and infection-independent manner. Plasma and/or sera of 221 COVID-19 patients from different cohorts, infected with successive SARS-CoV-2 variants including the Omicron, had detectable HERV-W ENV, which correlated with ENV expression in T lymphocytes and peaked with the disease severity. HERV-W ENV was also found in postmortem tissues of lungs, heart, gastrointestinal tract, brain olfactory bulb, and nasal mucosa from COVID-19 patients. Altogether, these results demonstrate that SARS-CoV-2 could induce HERV-W envelope protein expression and suggest its involvement in the immunopathogenesis of certain COVID-19-associated syndromes and thereby its relevance in the development of personalized treatment of patients.